文献速递腹部泌尿生殖MR

多参数MRI评估慢性肾病与肾间质纤维化的价值

Value of multiparametric magnetic resonance imaging for evaluating chronic kidney disease and renal fibrosis.
PubMed 文献 · Eur Radiol · 2023-05-06

该前瞻性研究纳入43例CKD患者和20例对照,采用T1 mapping、R2* mapping、IVIM和DWI扫描,发现肾皮质/髓质T1值随纤维化增加而升高,扩散参数逐渐降低;SVM模型联合cT1与csADC/cADC可高精度鉴别CKD及评估间质纤维化严重程度。

要点

  • 肾皮质和髓质T1值随间质纤维化加重而升高,扩散参数(ADC、Dt、sADC)逐渐降低。
  • SVM联合cT1与csADC鉴别CKD与对照的AUC为0.96,敏感度0.70、特异度0.92。
  • SVM联合cT1与cADC评估间质纤维化严重程度的AUC为0.96,准确率0.91。

核心结论

  • 多参数MRI联合T1 mapping与扩散成像可用于无创评估CKD和肾间质纤维化,有望为风险分层、诊断、治疗和预后提供信息。

研究设计与样本

  • 前瞻性研究,纳入43例CKD患者和20例对照,CKD组根据病理结果分为轻度和中重度亚组。
  • 扫描序列包括T1 mapping、R2* mapping、体素内不相干运动成像和扩散加权成像。
  • 采用单因素方差分析比较组间MRI参数,以年龄为协变量分析MRI参数与eGFR及肾间质纤维化的相关性,并使用支持向量机模型评估多参数MRI的诊断效能。

关键影像表现/征象

  • 与对照相比,肾皮质ADC(cADC)、髓质ADC(mADC)、皮质纯扩散系数(cDt)、髓质Dt(mDt)、皮质移位ADC(csADC)和髓质sADC(msADC)值在轻度组和中重度组逐渐降低。
  • 肾皮质T1(cT1)和髓质T1(mT1)值在轻度组和中重度组逐渐升高。

诊断标准与关键数值

  • cADC、mADC、cDt、mDt、cT1、mT1、csADC和msADC值与eGFR及间质纤维化显著相关(p < 0.001)。
  • SVM模型联合cT1和csADC鉴别CKD与对照:准确率0.84、敏感度0.70、特异度0.92、AUC 0.96。
  • SVM模型联合cT1和cADC评估间质纤维化严重程度:准确率0.91、敏感度0.95、特异度0.81、AUC 0.96。

临床应用与阅片要点

  • 阅片时可关注肾皮质和髓质T1值升高及扩散参数降低,这些征象提示CKD及间质纤维化可能。
  • 联合cT1与csADC或cADC的SVM模型可作为无创评估工具,辅助鉴别CKD和判断纤维化严重程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To identify optimized MRI markers for evaluating chronic kidney disease (CKD) and renal interstitial fibrosis (IF).

MATERIALS AND METHODS: This prospective study included 43 patients with CKD and 20 controls. The CKD group was divided into mild and moderate-to-severe subgroups based on pathological results. Scanned sequences included T1 mapping, R2* mapping, intravoxel incoherent motion imaging, and diffusion-weighted imaging. One-way analyses of variance were used to compare MRI parameters among groups. Correlations of MRI parameters with estimated glomerular filtration rate (eGFR) and renal IF were analyzed using age as covariates. The support vector machine (SVM) model was used to evaluate the diagnostic efficacy of multiparametric MRI.

RESULTS: Compared to control values, renal cortical apparent diffusion coefficient (cADC), medullary ADC (mADC), cortical pure diffusion coefficient (cDt), medullary Dt (mDt), cortical shifted apparent diffusion coefficient (csADC), and medullary sADC (msADC) values gradually decreased in the mild and moderate-to-severe groups, while cortical T1 (cT1) and medullary T1 (mT1) values gradually increased. Values of cADC, mADC, cDt, mDt, cT1, mT1, csADC, and msADC were significantly associated with eGFR and IF (p < 0.001). The SVM model indicated that multiparametric MRI combining cT1 and csADC can distinguish patients with CKD from controls with high accuracy (0.84), sensitivity (0.70), and specificity (0.92) (AUC: 0.96). Multiparametric MRI combining cT1 and cADC exhibited high accuracy (0.91), sensitivity (0.95), and specificity (0.81) for evaluating IF severity (AUC: 0.96).

CONCLUSION: Multiparametric MRI combining T1 mapping and diffusion imaging may be of clinical utility in non-invasive assessment of CKD and IF.

CLINICAL RELEVANCE STATEMENT: This study shows that multiparametric MRI combining T1 mapping and diffusion imaging may be clinically useful in the non-invasive assessment of chronic kidney disease (CKD) and interstitial fibrosis; this could provide information for risk stratification, diagnosis, treatment, and prognosis.

KEY POINTS: • Optimized MRI markers for evaluating chronic kidney disease and renal interstitial fibrosis were investigated. • Renal cortex/medullary T1 values increased as interstitial fibrosis increased; cortical shifted apparent diffusion coefficient (csADC) correlated significantly with eGFR and interstitial fibrosis. • Support vector machine (SVM) combining cortical T1 (cT1) and csADC/cADC effectively identifies chronic kidney disease and accurately predicts renal interstitial fibrosis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Hua, Qiu, Zhou, et al. Value of multiparametric magnetic resonance imaging for evaluating chronic kidney disease and renal fibrosis. Eur Radiol. 2023. PMID: 37148348. doi:10.1007/s00330-023-09674-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。